CSIMarket
 


Premier Biomedical Inc  (BIEI)
Other Ticker:  
 
 

BIEI's Net Cash Flow Growth by Quarter and Year

Premier Biomedical Inc's Net Cash Flow results by quarter and year




BIEI Net Cash Flow (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December -0.05 0.02 -0.02 -0.01
III Quarter September 0.03 0.05 -0.02 -0.01
II Quarter June 0.01 -0.07 -0.08 0.00
I Quarter March -0.01 0.00 0.19 0.00
FY   -0.02 0.00 0.07 -0.02



BIEI Net Cash Flow fourth quarter 2019 Y/Y Growth Comment
Premier Biomedical Inc in the fourth quarter 2019 recorded net cash outflow of $ -0.05 millions.

Looking into fourth quarter 2019 results within Biotechnology & Pharmaceuticals industry 17 other companies have achieved higher Net Cash Flow growth. While Premier Biomedical Inc' s Net Cash Flow no change of % ranks overall at the positon no. 532 in the fourth quarter 2019.




BIEI Net Cash Flow ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September -40 % - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Premier Biomedical Inc's fourth quarter 2019 Net Cash Flow $ -0.05 millions BIEI's Income Statement
Premier Biomedical Inc's fourth quarter 2018 Net Cash Flow $ 0.02 millions Quarterly BIEI's Income Statement
New: More BIEI's historic Net Cash Flow Growth >>


BIEI Net Cash Flow (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - -60 % - -
III Quarter September 200 % - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Cash Flow fourth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #18
Healthcare Sector #80
Overall #532

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow fourth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #18
Healthcare Sector #80
Overall #532
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Premier Biomedical Inc's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BIEI's IV. Quarter Q/Q Net Cash Flow Comment
Current accomplishment of -0.05 millions by Premier Biomedical Inc appear even more unfavourable compare to the 0.03 millions net cash outflow in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Premier Biomedical Inc achieved highest sequential Net Cash Flow growth. While Premier Biomedical Inc's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BIEI's IV. Quarter Q/Q Net Cash Flow Comment
Recent results of -0.05 millions by Premier Biomedical Inc appear even more unfavourable compare to the 0.03 millions net cash outflow in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Premier Biomedical Inc achieved highest sequential Net Cash Flow growth. While Premier Biomedical Inc's Net Cash Flow growth quarter on quarter, overall rank is .


Premier Biomedical Inc's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
Cumulative Net Cash Flow 12 Months Ending $ -0.02 $ 0.05 $ 0.08 $ 0.00 $ 0.00
Y / Y Net Cash Flow Growth (TTM) - - - - -94.9 %
Year on Year Net Cash Flow Growth Overall Ranking # 686 # 0 # 0 # 0 # 685
Seqeuential Net Cash Flow Change (TTM) - -29.61 % 3701.98 % -35.38 % -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 527 # 328 # 13 # 380 # 471




Cumulative Net Cash Flow growth Comment
Premier Biomedical Inc' has realized cumulative trailing twelve months net cash outflow of $ 0 millions in the Dec 31 2019 period.
The business is worsening as the cumulative net cash outflow is becoming larger from $ 0.05 millions for the period from Sep 30 2019 to Dec 31 2018 and $ 0.03 millions for the twelve months ending in the quarter Dec 31 2018.

In the Healthcare sector 104 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 0 to 686.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
-87.47 %
-600.52 %
-1619.24 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 6
Healthcare Sector # 105
Overall # 686

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
617.2 %
-291.12 %
-1619.24 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 78
S&P 500 # 527
Cumulative Net Cash Flow growth Comment
Premier Biomedical Inc' has realized cumulative trailing twelve months net cash outflow of $ 0 millions in the Dec 31 2019 period.
The business is getting worse as the cumulative net cash outflow is becoming larger from $ 0.05 millions in TTM ending quarter Sep 30 2019 and $ 0.03 millions from the TTM period ending Dec 31 2018.

In the Healthcare sector 104 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 0 to 686.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
-87.47 %
-600.52 %
-1619.24 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 6
Healthcare Sector # 105
Overall # 686

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
617.2 %
-291.12 %
-1619.24 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 78
S&P 500 # 527




Other Net Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
BIEI's Net Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for BIEI's Competitors
Net Cash Flow Growth for Premier Biomedical Inc's Suppliers
Net Cash Flow Growth for BIEI's Customers

You may also want to know
BIEI's Annual Growth Rates BIEI's Profitability Ratios BIEI's Asset Turnover Ratio BIEI's Dividend Growth
BIEI's Roe BIEI's Valuation Ratios BIEI's Financial Strength Ratios BIEI's Dividend Payout Ratio
BIEI's Roa BIEI's Inventory Turnover Ratio BIEI's Growth Rates BIEI's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Dec 31 2019 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2019
Xtl Biopharmaceuticals Ltd -1.03%$ -1.034 millions
Benitec Biopharma Inc -7.42%$ -7.424 millions
Ovid Therapeutics Inc -9.52%$ -9.519 millions
National Research Corporation-9.78%$ -9.776 millions
Dbv Technologies S a -10.96%$ -10.959 millions
Koninklijke Philips Nv-12.94%$ -12.945 millions
Taiwan Liposome Company Ltd -13.17%$ -13.171 millions
Itamar Medical Ltd -15.33%$ -15.334 millions
Cutera Inc -17.89%$ -17.893 millions
Lifevantage Corp-21.22%$ -21.222 millions
Fonar Corporation-23.86%$ -23.857 millions
Sanofi-24.81%$ -24.809 millions
Trillium Therapeutics Inc -29.49%$ -29.490 millions
Supernus Pharmaceuticals inc -29.86%$ -29.857 millions
Biolinerx Ltd -33.39%$ -33.386 millions
Xoma Corporation-37.12%$ -37.119 millions
Aeterna Zentaris Inc -37.93%$ -37.931 millions
Otonomy Inc -39.26%$ -39.259 millions
Morphosys Ag-40.64%$ -40.645 millions
Collegium Pharmaceutical Inc -41.88%$ -41.877 millions
Biohaven Ltd -44.33%$ -44.331 millions
Nabriva Therapeutics Plc-46.95%$ -46.948 millions
Neovasc Inc -47.21%$ -47.206 millions
Johnson and Johnson-48.51%$ -48.513 millions
Genetic Technologies Limited-50.06%$ -50.065 millions
Liquidia Corporation-54.34%$ -54.337 millions
Viveve Medical Inc -55.21%$ -55.209 millions
Motus Gi Holdings Inc -56.90%$ -56.902 millions
Cryoport inc -57.80%$ -57.799 millions
Kazia Therapeutics Limited-58.80%$ -58.796 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com